Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | CTSK | P43235 | 7/20 | 0.45 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8544339 | 1.00 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CTSKACENPC1 | |
| SCHEMBL8548308 | 0.90 | NPC1 (0.48) | ALDH1A1SMN1; SMN2CTSKNPC1RAB9A | |
| SCHEMBL8548300 | 0.90 | NPC1 (0.48) | ALDH1A1SMN1; SMN2CTSKNPC1RAB9A | |
| SCHEMBL8544513 | 0.89 | RAB9A (0.47) | ALDH1A1SMN1; SMN2CTSKRAB9A | |
| SCHEMBL8544518 | 0.89 | RAB9A (0.47) | ALDH1A1SMN1; SMN2CTSKRAB9A | |
| SCHEMBL8546903 | 0.89 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2CTSKNPSR1 | |
| SCHEMBL8546896 | 0.89 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2CTSKNPSR1 | |
| SCHEMBL8545354 | 0.86 | SLC6A12 (0.46) | ALDH1A1SMN1; SMN2CTSKLMNA | |
| SCHEMBL8543361 | 0.86 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2CTSKMAPT | |
| SCHEMBL8543367 | 0.86 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2CTSKMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | claimed |
| EP-0564924-A2 | 2-Oxoethyl derivatives as immunosuppressants | Bayer Corporation (US) | 1993-10-13 | — | — | EP | claimed |
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | disclosed |
| US-5686424-A | FOR TREATING INFLAMMATION | MILES INC. (US) | 1997-11-11 | — | — | US | disclosed |